Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

Atherosclerotic cardiovascular disease (ASCVD) causes significant morbidity and mortality globally. Most of the chemicals specifically target certain pathways and minimally impact other diseases associated with ASCVD. Moreover, interactions of these drugs can cause toxic reactions. Consequently, the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiao-Lan Zhao, Zhang-Jing Cao, Ke-Di Li, Fei Tang, Li-Yue Xu, Jing-Nan Zhang, Dong Liu, Cheng Peng, Hui Ao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	gallic acid diabetes hypertension hyperlipidemia atherosclerosis ASCVD
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1515172/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prophylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE−/− mice
by: Yaze Wang, et al.
Published: (2025-01-01)

A 10-Year Risk Assessment and Primary Prevention Study of Atherosclerotic Cardiovascular Disease Among Adult Patients in Saudi Arabia: A Cross-Sectional Study
by: Abdulhameed Alkhalaf, et al.
Published: (2025-01-01)

Therapeutic target genes and regulatory networks of gallic acid in cervical cancer
by: Zhixi You, et al.
Published: (2025-01-01)

Elevated Fasting C-Peptide Levels Correlate with Increased 10-Year Risk of Atherosclerotic Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes Patients
by: Zha XY, et al.
Published: (2025-01-01)

Effect of gallic acid on ram semen spermatological parameters at +4 ⁰c storage
by: Şükrü Güngör, et al.

Gallic acid showed neuroprotection against endoplasmic reticulum stress in rats
by: Abdulmutalip Karaaslanlı, et al.
Published: (2025-01-01)

Morphological adaptation of loan words : a case of noun Gallicisms in Slovak
by: Daniel Vojtek
Published: (2024-10-01)

Encapsulation of Gallic Acid with Acid-Modified Low Dextrose Equivalent Potato Starch Using Spray-and Freeze-Drying Techniques
by: Sepelevs Igor, et al.
Published: (2018-09-01)

Protective effects of gallic acid against nickel-induced kidney injury: impact of antioxidants and transcription factor on the incidence of nephrotoxicity
by: Areej I. Alhazmi, et al.
Published: (2024-12-01)

Gallic acid alleviates exercise-induced muscle damage by inhibiting mitochondrial oxidative stress and ferroptosis
by: Likai Yu, et al.
Published: (2025-01-01)

Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women
by: Betânia Rodrigues dos Santos, et al.
Published: (2025-01-01)

Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders
by: Maojun Cheng, et al.
Published: (2025-01-01)

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
by: Can Huang, et al.
Published: (2025-01-01)

Gallic acid protects intervertebral disc cells from ferroptosis and alleviates intervertebral disc degeneration by regulating key factors of oxidative stress
by: Zaishi Zhu, et al.
Published: (2025-02-01)

Liquid-phase synthesis of magnesium phosphates in the presence of gallic acid
by: O.N. Musskaya, et al.
Published: (2024-12-01)

Polyphenol components in black chokeberry (Aronia melanocarpa) as clinically proven diseases control factors—an overview
by: Ningxuan Gao, et al.
Published: (2024-05-01)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
by: Zhiyue Wang, et al.
Published: (2024-12-01)

Epidemiological aspects of nephrolithiasis and chronic diseases of the cardiovascular system combination
by: R. V. Royuk, et al.
Published: (2020-03-01)

Management recommendations to reduce cardiac risk in chronic epilepsy
by: Trudy D. Pang, et al.
Published: (2025-03-01)

Factors Associated with Goal Achievement in Patients with Dyslipidemia in Primary Care
by: Pinto-González, Gustavo, et al.
Published: (2025-01-01)

Recommendations for the primary prevention of atherosclerotic cardiovascular disease in primary care: a systematic guideline review
by: Maren Bredehorst, et al.
Published: (2025-01-01)

Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs
by: Fei Yu, et al.
Published: (2025-01-01)

QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores
by: Subramanian Kannan, et al.
Published: (2024-12-01)

Verbascoside exerts an anti-atherosclerotic effect by regulating liver glycerophospholipid metabolism
by: Peng Lei, et al.
Published: (2023-11-01)

Pharmacological regression of atherosclerotic plaque in patients with type 2 diabetes
by: Loredana Bucciarelli, et al.
Published: (2025-03-01)

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01)

Identification of critical endoplasmic reticulum stress-related genes in advanced atherosclerotic plaque
by: Ning Zhao, et al.
Published: (2025-01-01)

Mechanisms of inflammatory microenvironment formation in cardiometabolic diseases: molecular and cellular perspectives
by: Menghua Liu, et al.
Published: (2025-01-01)

Characterization and Nutritional Intervention Effects of <i>Canna edulis</i> Type 5 Resistant Starch in Hyperlipidemia Mice
by: Houxier Li, et al.
Published: (2025-01-01)

Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01)

The multifaceted anti-atherosclerotic properties of herbal flavonoids: A comprehensive review
by: Meiwen Huang, et al.
Published: (2025-01-01)

Lack of intracranial atherosclerosis in various atherosclerotic mouse models
by: Diewertje I Bink, et al.
Published: (2025-01-01)

Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD
by: Monika Rac, et al.
Published: (2024-12-01)

Association between composite dietary antioxidant index and hyperlipidemia in adults based on the NHANES
by: Kaidi Nie, et al.
Published: (2025-01-01)

Klotho enhances stability of chronic kidney disease atherosclerotic plaques by inhibiting GRK2/PLC-β-mediated endoplasmic reticulum stress in macrophages via modulation of the ROS/SHP1 pathway
by: Zhe Li, et al.
Published: (2024-12-01)

Témoignages de la Guerre des Gaules dans le bassin clermontois, nouveaux apports
by: Yann Deberge, et al.
Published: (2015-04-01)

Comparison of centrifugal-membrane hybrid plasmapheresis and centrifugation therapeutic plasma exchange in hyperlipidemia
by: ZHANG Bin, et al.
Published: (2024-12-01)

Automated process assessment of primary healthcare for hyperlipidemia: preliminary findings and implications form Anhui, China
by: Ningjing Yang, et al.
Published: (2025-01-01)

Combination of Mangosteen (Garcinia mangostana L.) Pericarp Extract and Physical Exercise Decreases Atherosclerotic Lesions in Atherogenic Diet-Fed Rats
by: Andreas Arie Setiawan, et al.
Published: (2024-12-01)

Awareness and Perceptions towards the Role of Systemic Inflammation and High-Sensitivity C-reactive Protein as a Biomarker in Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: The Multinational FLAME-ASCVD Survey amongst Cardiologists
by: Nikolaus Marx, et al.
Published: (2024-12-01)